← Eichor · All briefs

NCT04323657 — Non Hodgkin Lymphoma trial site landscape

Public-registry site landscape for NCT04323657, a Non Hodgkin Lymphoma study sponsored by TCR2 Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT04323657 (registry record)
SponsorTCR2 Therapeutics
Condition(s)Non Hodgkin Lymphoma; Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma
PhasePHASE1 / PHASE2
Listed sites3
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04323657 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.